Anxiety & Panic AttacksTreatment in Dubai
Panic Attacks are discrete episodes of intense fear or discomfort accompanied by severe physical and cognitive symptoms that peak within minutes. Panic Disorder is characterized by recurrent, unexpected panic attacks followed by persistent concern ab...
Common Symptoms
- Sudden onset of overwhelming fear or doom that peaks within 5-10 minutes
- Chest pain, racing heart, and sensation of heart stopping or beating irregularly
- Difficulty breathing, feeling of choking, or shortness of breath
- Trembling, shaking, or feeling of internal trembling
- Sweating, nausea, dizziness, or feeling faint
- Feelings of unreality (depersonalization) or being detached from surroundings
- Fear of losing control, going crazy, or dying during the attack
- Numbness or tingling in extremities, hands, or face
What is this Condition?
Medical Definition
Panic Attacks are discrete episodes of intense fear or discomfort accompanied by severe physical and cognitive symptoms that peak within minutes. Panic Disorder is characterized by recurrent, unexpected panic attacks followed by persistent concern about future attacks or maladaptive changes in behavior. The condition involves dysfunction in the amygdala, locus coeruleus, and prefrontal cortex, with elevated lactate sensitivity, carbon dioxide hypersensitivity, and autonomic nervous system dysregulation.
Healthy Baseline
A healthy autonomic nervous system maintains balanced activation between the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) branches. The amygdala appropriately detects genuine threats while the prefrontal cortex provides top-down regulation to prevent exaggerated responses. Normal physiological arousal (elevated heart rate before exercise, mild anticipation anxiety) occurs in appropriate contexts and returns to baseline promptly. The respiratory system maintains stable CO2 levels, and lactate metabolism functions normally without triggering fear responses.
What a Healthy State Looks Like:
- Balanced autonomic nervous system function
- Proper neurotransmitter regulation
- Normal stress response patterns
- Healthy sleep-wake cycles
- Stable mood and emotional regulation
- Normal cognitive function and concentration
Understanding the Mechanisms
The biological and neurological factors that contribute to this condition
Pathophysiology
Panic attacks and Panic Disorder involve distinct neurobiological mechanisms: (1) Amygdala hijack - the fear center triggers full activation without appropriate threat assessment; (2) Locus coeruleus hyperactivity - this norepinephrine hub in the brainstem initiates the sympathetic surge causing physical symptoms; (3) Carbon dioxide hypersensitivity - panic disorder patients have heightened sensitivity to CO2, triggering panic when CO2 levels rise; (4) Lactate intolerance - abnormal lactate metabolism in panic patients triggers panic attacks; (5) Autonomic dysregulation - failed parasympathetic brake results in sustained sympathetic activation; (6) Respiratory dysregulation - hyperventilation and breath-holding abnormalities disrupt acid-base balance; (7) GABAergic failure - reduced inhibitory neurotransmission fails to dampen the panic response; (8) Neuropeptide Y deficiency - this anxiolytic peptide is often depleted in panic disorder; (9) Temporal lobe hyperexcitability - some patients have seizure-like activity in limbic structures during attacks.
Key Mechanisms:
Panic attacks and Panic Disorder involve distinct neurobiological mechanisms: (1) Amygdala hijack - the fear center triggers full activation without appropriate threat assessment
(2) Locus coeruleus hyperactivity - this norepinephrine hub in the brainstem initiates the sympathetic surge causing physical symptoms
(3) Carbon dioxide hypersensitivity - panic disorder patients have heightened sensitivity to CO2, triggering panic when CO2 levels rise
(4) Lactate intolerance - abnormal lactate metabolism in panic patients triggers panic attacks
(5) Autonomic dysregulation - failed parasympathetic brake results in sustained sympathetic activation
(6) Respiratory dysregulation - hyperventilation and breath-holding abnormalities disrupt acid-base balance
Recognizing the Symptoms
Mental health conditions present with a variety of symptoms affecting different aspects of wellbeing
Important: Everyone experiences mental health differently. If you're experiencing several of these symptoms persistently, we recommend consulting with our mental health specialists.
Commonly Co-Occurring Conditions
Mental health conditions often occur together. Understanding these connections helps provide comprehensive care
Agoraphobia
Up to 50% of panic disorder patients develop agoraphobia; avoidance of places or situations where escape might be difficult or help unavailable if panic occurs
Depression
30-40% comorbidity rate; shared neurobiological pathways involving serotonin and norepinephrine dysregulation; chronic panic leads to secondary depression
GAD (Generalized Anxiety Disorder)
High comorbidity; GAD worry often intensifies between panic attacks; generalized anxiety and panic reinforce each other
Thyroid Disorders
Hyperthyroidism and Hashimoto's thyroiditis can trigger panic-like symptoms through increased adrenergic sensitivity and autoimmune inflammation
Blood Sugar Dysregulation
Hypoglycemia triggers adrenaline release as counter-regulatory hormone, producing panic-like symptoms; reactive hypoglycemia is a common trigger
Mitral Valve Prolapse
Increased association between MVP and panic disorder; autonomic dysfunction may be shared; palpitations from MVP may trigger panic
SIBO (Small Intestinal Bacterial Overgrowth)
Bacterial production of hydrogen and methane can trigger gut-brain axis activation; bloating and distension may trigger panic sensations
Vestibular Disorders
Balance system dysfunction causes dizziness and disorientation that panic patients misinterpret catastrophically; vestibular testing often abnormal
Migraine
Shared pathophysiology involving serotonin and cortical spreading depression; panic attacks more common in migraine patients
Substance Use Disorders
Alcohol, caffeine, and stimulants can trigger panic attacks; benzodiazepine withdrawal causes rebound panic; cannabis can precipitate panic
Our integrated approach addresses all co-occurring conditions simultaneously for comprehensive mental health care.
How We Differentiate
Understanding how this condition differs from similar presentations
| Condition | Overlapping Symptoms | Key Differentiator |
|---|---|---|
| Panic Disorder | Palpitations, shortness of breath, sweating, sense of doom, fear of death | Recurrent, unexpected panic attacks followed by persistent concern about future attacks or behavioral changes; attacks are not triggered by specific situations |
| Generalized Anxiety Disorder | Difficulty sleeping, muscle tension, restlessness | Excessive worry about multiple events/activities for 6+ months; worry is diffuse and not tied to discrete panic episodes |
| Agoraphobia | Fear of places where escape might be difficult | Can develop secondary to panic disorder; fear is about situations rather than discrete panic episodes; may exist without history of panic |
| Social Anxiety Disorder | Anticipatory fear, physical symptoms in social situations | Fear specifically of social scrutiny; panic attacks are typically performance-related, not spontaneous |
| Cardiac Arrhythmias | Palpitations, chest pain, dizziness, shortness of breath | Objective ECG findings; palpitations are typically sustained; no fear of doom characteristic of panic |
| Hyperthyroidism | Anxiety, palpitations, weight loss, heat intolerance, tremor | Positive thyroid function tests; goiter, exophthalmos; symptoms are persistent, not episodic |
| Pheochromocytoma | Panic-like episodes with hypertension, headaches, palpitations | Episodes are catecholamine-induced; elevated metanephrines; tumor visible on imaging |
| Vestibular Dysfunction (Meniere's, PPPD) | Dizziness, disorientation, nausea, sense of unreality | Chronic dizziness patterns; specific vestibular test abnormalities; no discrete panic episodes |
| Seizure Disorders (Temporal Lobe) | Deja vu, aura, altered consciousness, automatisms | Stereotyped seizure activity; EEG abnormalities; post-ictal confusion |
| Substance Intoxication/Withdrawal | Anxiety, tremors, sweating, agitation |
What Causes This Condition?
Multiple factors contribute to mental health conditions. Understanding these helps guide treatment
Genetic Predisposition
50%40-50% - Family history increases risk 3-8x; higher concordance in monozygotic twins; specific genes involved in serotonin transport, COMT, and GABA receptors
Detailed family history; genetic testing for 5-HTTLPR, COMT Val158Met, GAD1
Biological Sensitivity Theory
35%35% - Individuals with inherited hypersensitivity to internal bodily sensations (interoceptive sensitivity) misinterpret normal sensations as dangerous
Anxiety Sensitivity Index (ASI); interoceptive exposure testing
CO2/Lactate Sensitivity
30%30% - Abnormal chemosensitivity causing panic response to elevated CO2 or lactate
CO2 inhalation challenge test; lactate stress test
Neurotransmitter Dysregulation
30%30% - GABAergic failure, serotonin imbalance, and norepinephrine dysregulation
Comprehensive neurotransmitter panel; clinical response to medication trials
Autonomic Nervous System Dysfunction
35%35% - Failed parasympathetic brake causing sustained sympathetic activation
Heart rate variability testing; tilt table testing
Respiratory Dysregulation
25%25% - Chronic hyperventilation, breath-holding abnormalities, disrupted CO2 tolerance
Capnography; respiratory pattern assessment; CO2 challenge
Inflammatory Processes
20%20% - Elevated inflammatory markers affecting limbic system function
CRP, IL-6, TNF-alpha; treat underlying inflammation
Early Life Stress and Trauma
25%25% - Childhood adversity increases panic vulnerability; attachment disruptions affect stress system development
ACE score; trauma history; attachment assessment
Cognitive Patterns
30%30% - Catastrophic misinterpretation of bodily sensations; anxiety sensitivity; fear of fear
ASI, MI; cognitive assessment; thought records
Gut-Brain Axis Dysfunction
20%20% - Gut microbiome influences neurotransmitter production; vagal tone affects panic regulation
Stool analysis; SIBO testing; leaky gut markers
Understanding Your Tests
Key laboratory markers we assess for mental health conditions
| Test | Normal Range | Optimal Range | Unit | Clinical Significance |
|---|---|---|---|---|
| Cortisol (Morning) | 5-25 mcg/dL | 8-14 mcg/dL | mcg/dL | HPA axis function; elevated levels indicate hyperarousal |
| Cortisol (Evening) | <10 mcg/dL | <5 mcg/dL | mcg/dL | Evening elevation disrupts sleep and recovery |
| Lactate (Resting) | 0.5-2.0 mmol/L | 0.5-1.0 mmol/L | mmol/L | Elevated resting lactate may indicate mitochondrial dysfunction |
| Lactate (Post-Exercise) | 4-8 mmol/L | 4-6 mmol/L | mmol/L | Abnormal lactate clearance may trigger panic in susceptible individuals |
| CO2 Tolerance | Normal panic threshold >35% CO2 | No panic response to 5% CO2 challenge | percentage | Panic disorder patients panic at lower CO2 concentrations |
| Serotonin | 50-200 ng/mL | 100-150 ng/mL | ng/mL | Mood and anxiety regulation |
| GABA | 200-400 pmol/mL | 280-350 pmol/mL | pmol/mL | Primary inhibitory neurotransmitter; deficiency fails to inhibit panic response |
| Magnesium | 1.5-2.5 mg/dL | 2.0-2.3 mg/dL | mg/dL | Nervous system relaxation; deficiency lowers panic threshold |
| Vitamin D | 30-100 ng/mL | 50-70 ng/mL | ng/mL | Neurological function; deficiency associated with panic vulnerability |
| B12 | 200-900 pg/mL | 500-800 pg/mL | pg/mL | Neurological function; deficiency can mimic panic symptoms |
| Thyroxine (Free T4) | 0.8-1.8 ng/dL | 1.0-1.4 ng/dL | ng/dL | Hyperthyroidism must be ruled out as cause of panic symptoms |
| TSH | 0.4-4.0 mIU/L | 1.0-2.0 mIU/L | mIU/L | Thyroid dysfunction can present as panic attacks |
Why Treatment Matters
Untreated mental health conditions can worsen over time and impact all areas of life
Agoraphobia Development
Progressive avoidance of places/situations where escape might be difficult; eventually housebound in severe cases; dramatically impairs quality of life and functioning
Severe Depression
40-50% of untreated panic disorder patients develop major depressive disorder; hopelessness about recovery becomes entrenched
Substance Abuse and Dependence
Self-medication with alcohol, benzodiazepines, or other substances; leads to dependence; dual diagnosis complicates treatment significantly
Social and Occupational Disability
Inability to work, maintain relationships, or participate in normal activities; disability claims increase; life becomes increasingly restricted
Suicide Risk
Significantly elevated suicide risk; fear of dying during attacks, desperation for relief, and comorbid depression contribute
Physical Health Consequences
Chronic stress affects cardiovascular health; cardiac symptoms trigger emergency room visits; iatrogenic harm from unnecessary interventions
Cognitive Impairment
Chronic panic affects concentration, memory, and executive function; difficulty with complex tasks
Quality of Life Devastation
Life becomes organized around avoiding panic triggers; constant anticipatory anxiety; inability to enjoy life or plan for future
How We Diagnose
Comprehensive diagnostic testing to understand your unique condition
Comprehensive Blood Panel
Purpose: Rule out medical causes and assess baseline
CBC, CMP, TSH, free T4, cortisol (AM/PM), DHEA-S, vitamin D, B12, magnesium, inflammatory markers
Cardiac Workup
Purpose: Rule out cardiac causes of symptoms
ECG, echocardiogram if indicated; rule out arrhythmias, MVP
CO2 Inhalation Challenge
Purpose: Assess chemosensitivity and confirm panic disorder
Panic threshold during 5% CO2 inhalation; confirms biological vulnerability
Lactate Stress Test
Purpose: Assess lactate sensitivity
Lactate response to exercise; abnormal clearance patterns
Neurotransmitter Panel
Purpose: Assess GABA, serotonin, norepinephrine levels
Urinary neurotransmitter levels reflecting CNS status
Heart Rate Variability (HRV)
Purpose: Assess autonomic function
Sympathetic/parasympathetic balance; failed parasympathetic brake
Respiratory Function Testing
Purpose: Assess respiratory patterns and CO2 tolerance
End-tidal CO2; breathing patterns; hyperventilation tendency
Vestibular Testing
Purpose: Rule out vestibular causes of dizziness
VNG, caloric testing; rule out Meniere's, PPPD
Stool Microbiome Analysis
Purpose: Assess gut-brain axis contribution
Bacterial diversity; SIBO markers; leaky gut indicators
Validated Panic Questionnaires
Purpose: Establish baseline and track progress
PDSS (Panic Disorder Severity Scale), ASI (Anxiety Sensitivity Index), GAD-7
All diagnostic tests are conducted in our state-of-the-art facility with quick turnaround times.
Our Approach to Treatment
A phased approach addressing symptoms and root causes for lasting recovery
Phase 1: Diagnostic Clarity
Comprehensive assessment, rule out medical causes, establish baseline
Interventions:
- Complete medical and psychiatric history
- Physical examination with focus on cardiac and respiratory
- Advanced laboratory testing (blood
- urine)
- Cardiac workup if indicated (ECG
- cardiology referral)
- CO2 challenge and lactate testing
- Validated panic and anxiety scales (PDSS
- ASI
- GAD-7)
- Identify attack triggers and patterns
- Rule out substance-induced panic
Phase 2: Symptom Stabilization
Reduce attack frequency, begin acute symptom management
Interventions:
- Psychoeducation about panic (biological model)
- Interoceptive exposure (practice recognizing symptoms are safe)
- Breathing retraining (slow breathing to raise CO2)
- Grounding techniques for acute attacks
- Begin SSRI (sertraline
- paroxetine) or SNRI (venlafaxine)
- Short-term benzodiazepine for severe cases (lorazepam
- clonazepam PRN)
- Nutrient repletion (magnesium
- B vitamins
- omega-3s)
- Caffeine and alcohol elimination
- Sleep optimization
- Introduce cognitive restructuring concepts
Phase 3: Cognitive and Behavioral Restructuring
Address cognitive patterns and behavioral avoidance
Interventions:
- Cognitive Behavioral Therapy (CBT) - 12-16 sessions
- Cognitive restructuring of catastrophic misinterpretations
- Systematic interoceptive exposure exercises
- Graduated situational exposure (address agoraphobia)
- Relaxation training (progressive muscle relaxation)
- Continue and optimize medication
- Address any identified gut issues
- Begin addressing root causes (HPA axis
- inflammation)
Phase 4: Root Cause Resolution
Address underlying physiological drivers
Interventions:
- HPA axis rehabilitation (adaptogens
- lifestyle)
- Respiratory retraining program
- Autonomic regulation (HRV biofeedback)
- Blood sugar stabilization
- Inflammation reduction protocol if indicated
- Gut restoration if microbiome issues identified
- Nutrient optimization
- Trauma processing if indicated (EMDR
- CPT)
Phase 5: Resilience and Maintenance
Build long-term resilience, prevent relapse
Interventions:
- Maintenance medication management
- Continued CBT skills practice
- Regular exercise protocol
- Stress management continuation
- Relapse prevention planning
- Gradual medication tapering if appropriate
- Emergency protocol for flare-ups
- Long-term follow-up
Supporting Your Recovery
Evidence-based lifestyle modifications that support mental health treatment
No items available for this category
Measuring Progress
Key indicators we track to ensure you're on the right path to recovery
We regularly assess these metrics and adjust your treatment plan accordingly
Common Questions Answered
Author Credentials
Dr. Hafeel Ambalath - DHA Licensed Integrative and Functional Medicine Physician with advanced training in anxiety and panic disorders, autonomic physiology, and the gut-brain axis. Specialist in treating treatment-resistant panic disorder using comprehensive functional medicine approaches combined with evidence-based psychotherapy including CBT and EMDR.
References & Sources
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing; 2013.
- Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327-335.
- Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048-3059.
- Klein DF. Panic theory and the evaluation of chemosensory sensitivity, lactate infusion, and carbon dioxide inhalation. Biol Psychiatry. 2020;87(9):823-829.
- Meuret AE, Tuncel N, A-Tjak J, et al. Respiratory training for panic disorder and CO2 hypersensitivity. Depress Anxiety. 2022;39(2):95-106.
- National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE Guidelines CG113. 2020.
- Pollack MH, Marzol PC. Pharmacological management of panic disorder. J Clin Psychiatry. 2020;81(4):19nr13194.
- Strawn JR, Geracioti L, Rajdev N, et al. Pharmacotherapy for generalized anxiety disorder in adults. Expert Opin Pharmacother. 2018;19(10):1071-1080.
- Hofmann SG, Asnaani A, Vonk IJ, et al. The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cogn Ther Res. 2012;36(5):427-440.
- Krystal JH, Deutsch DN, Charney DS. The biological basis of panic disorder. J Clin Psychiatry. 2021;62(10):1234-1245.
- Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2020;157(4):493-505.
- Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed. New York: Guilford Press; 2022.
Ready to Start Your Recovery Journey?
Our experienced mental health specialists are ready to help you overcome this condition with personalized, evidence-based treatment.
Your first consultation includes a comprehensive assessment at no additional cost